Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Boyapati, Ray Kiran"'
Autor:
Maconi, Giovanni, Bosetti, Cristina, De Monti, Alberta, Boyapati, Ray Kiran, Shelton, Edward, Piazza, Nicole, Carvalhas Gabrielli, Anna Maria, Lenti, Marco Vincenzo, Bezzio, Cristina, Ricci, Chiara, Greco, Salvatore, Romeo, Samanta, Giangregorio, Francesco, Gridavilla, Daniele, Tagliani, Fabio, Massari, Alessandro, Pastorelli, Luca, Di Sabatino, Antonio, Saibeni, Simone, Alicante, Saverio, Ferretti, Francesca, Rizzardini, Giuliano, Galli, Massimo, Ardizzone, Sandro
Publikováno v:
In Digestive and Liver Disease March 2021 53(3):263-270
Autor:
Boyapati, Ray Kiran
Background The inflammatory bowel diseases (IBD) ulcerative colitis (UC) and Crohn’s disease (CD) are chronic relapsing inflammatory disorders which have a rising incidence and cause significant morbidity. There are currently several treatment opti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______463::2db7059842796a3820cd03bae948208c
http://hdl.handle.net/1842/33169
http://hdl.handle.net/1842/33169
Publikováno v:
BOYAPATI, RAY KIRAN, Ho, G-T & Satsangi, J 2016, ' Can Thiopurines Prevent Formation of Antibodies Against Tumor Necrosis Factor Antagonists After Failure of These Therapies ', Clinical Gastroenterology and Hepatology . https://doi.org/10.1016/j.cgh.2016.09.152
Anti-tumor necrosis factor α (anti-TNF) therapy has revolutionised the treatment of Crohn’s disease (CD). However, primary nonresponse occurs in an estimated 13-40% of patients1 and secondary loss of response in 23%-46% of patients after 12 months
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0948c4a978d161bf3cfc4d76a023a85d
https://doi.org/10.1016/j.cgh.2016.09.152
https://doi.org/10.1016/j.cgh.2016.09.152
Publikováno v:
BOYAPATI, RAY KIRAN, Kalla, R, Satsangi, J & Ho, G-T 2016, ' Biomarkers in search of Precision Medicine in IBD ', The American Journal of Gastroenterology, vol. 111, no. 12 . https://doi.org/10.1038/ajg.2016.441
The completion of the human genome project in 2003 represented a major scientific landmark, ushering in a new era with hopes and expectations of fresh insights into disease mechanisms and treatments. In inflammatory bowel disease (IBD), many importan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc6eacb3416c1d66ffc04d2a8edea8e1
http://ora.ox.ac.uk/objects/uuid:
http://ora.ox.ac.uk/objects/uuid:
Autor:
Nicholas A. Kennedy, Rahul Kalla, Nicholas T. Ventham, Rebecca J Pattenden, Gwo-Tzer Ho, Ray Boyapati, David C. Wilson, Hazel E. Drummond, Elaine R. Nimmo, Alex Adams, Micaela Rios Visconti, Jack Satsangi
Publikováno v:
Kalla, R, Kennedy, N, Ventham, N T, BOYAPATI, RAY KIRAN, Adams, A T, Nimmo, E, Visconti, M, Drummond, H, Ho, G-T, Pattenden, R, Wilson, D C & Satsangi, J 2016, ' Serum Calprotectin-A novel diagnostic and prognostic marker in Inflammatory Bowel Diseases ', The American Journal of Gastroenterology . https://doi.org/10.1038/ajg.2016.342
IntroductionThere is an unmet need for novel blood based biomarkers that offer timely and accurate diagnostic and prognostic testing in Inflammatory Bowel Diseases (IBD). We aimed to investigate the diagnostic and prognostic utility of serum calprote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::214b3aa66190a1307eb22bd184b2b66f
https://pubmed.ncbi.nlm.nih.gov/28718125
https://pubmed.ncbi.nlm.nih.gov/28718125
Autor:
Brenda Wren
First published in 1845, this directory has established an enviable reputation for the quantity and extent of its information on UK-registered medical practitioners. It provides mini career profiles of doctors listed A-Z by surname. Each record conta